Searchable abstracts of presentations at key conferences in endocrinology

ea0081rc3.6 | Rapid Communications 3: Thyroid 1 | ECE2022

The mRNA of fibronectin 1 and of the integrin subunit alpha V are powerful prognostic indicators in papillary thyroid carcinoma

Vitale Mario , Marotta Vincenzo , Tortora Anna , Izzo Giulia , Rocco Domenico

Integrins are cell-extracellular matrix adhesion molecules considered functionally related to the development of cancer metastasis. Starting from the dataset of mRNA-seq of papillary thyroid carcinoma (PTC) from the TCGA, we determined the expression of fibronectin 1 (FN1) and fibronectin-binding integrins in PTC. We then analyzed the association of the expression of these two genes with the driver genes, the stage of the disease and its outcome. 355 PTCs and 58 normal thyroid...

ea0081p394 | Environmental Endocrinology | ECE2022

Synergism between bisphenol a exposure and overweight/obesity in increasing the malignancy risk in a cohort of patients with thyroid nodules

Marotta Vincenzo , Grumetto Lucia , Neri Ilaria , Russo Giacomo , Tortora Anna , Izzo Giulia , Rocco Domenico , Vitale Mario

Introduction: The plasticizer Bisphenol A (BPA) is an endocrine disruptor with thyroid interfering activity. Obesity is a recognized risk factor for thyroid cancer. A recent study showed that subjects with BMI ≥ 25 are more prone to BPA-related thyroid disruption. To date, few and controversial experimental and epidemiological data provide weak evidence about a correlation between BPA exposure and thyroid cancer development. Aim of the present study was to assess a possi...

ea0081ep789 | Pituitary and Neuroendocrinology | ECE2022

GH provocative tests stimulate the growth in children without GH deficiency

Tortora Anna , Marotta Vincenzo , Izzo Giulia , Rocco Domenico , Clemente Gennaro , Vitale Mario

Introduction: GH deficiency (GHD) is a clinical disorder characterized by pathological short stature in the child, altered body composition, impaired psychological well-being and reduced quality of life. These alterations are almost always reversible after recombinant human GH (rhGH) administration, which is currently the only accepted treatment for the subjects with GHD. Secretory dysfunction is confirmed when GH peak does not reach the established cut-off in at least two dif...